Literature DB >> 29939268

Evaluating large-scale propensity score performance through real-world and synthetic data experiments.

Yuxi Tian1, Martijn J Schuemie2, Marc A Suchard1,3,4.   

Abstract

Background: Propensity score adjustment is a popular approach for confounding control in observational studies. Reliable frameworks are needed to determine relative propensity score performance in large-scale studies, and to establish optimal propensity score model selection methods.
Methods: We detail a propensity score evaluation framework that includes synthetic and real-world data experiments. Our synthetic experimental design extends the 'plasmode' framework and simulates survival data under known effect sizes, and our real-world experiments use a set of negative control outcomes with presumed null effect sizes. In reproductions of two published cohort studies, we compare two propensity score estimation methods that contrast in their model selection approach: L1-regularized regression that conducts a penalized likelihood regression, and the 'high-dimensional propensity score' (hdPS) that employs a univariate covariate screen. We evaluate methods on a range of outcome-dependent and outcome-independent metrics.
Results: L1-regularization propensity score methods achieve superior model fit, covariate balance and negative control bias reduction compared with the hdPS. Simulation results are mixed and fluctuate with simulation parameters, revealing a limitation of simulation under the proportional hazards framework. Including regularization with the hdPS reduces commonly reported non-convergence issues but has little effect on propensity score performance. Conclusions: L1-regularization incorporates all covariates simultaneously into the propensity score model and offers propensity score performance superior to the hdPS marginal screen.

Entities:  

Mesh:

Year:  2018        PMID: 29939268      PMCID: PMC6280944          DOI: 10.1093/ije/dyy120

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  40 in total

1.  High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications.

Authors:  E Garbe; S Kloss; M Suling; I Pigeot; S Schneeweiss
Journal:  Eur J Clin Pharmacol       Date:  2012-07-05       Impact factor: 2.953

2.  Regularized Regression Versus the High-Dimensional Propensity Score for Confounding Adjustment in Secondary Database Analyses.

Authors:  Jessica M Franklin; Wesley Eddings; Robert J Glynn; Sebastian Schneeweiss
Journal:  Am J Epidemiol       Date:  2015-08-01       Impact factor: 4.897

3.  A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.

Authors:  Peter C Austin; Paul Grootendorst; Geoffrey M Anderson
Journal:  Stat Med       Date:  2007-02-20       Impact factor: 2.373

4.  Accuracy of an automated knowledge base for identifying drug adverse reactions.

Authors:  E A Voss; R D Boyce; P B Ryan; J van der Lei; P R Rijnbeek; M J Schuemie
Journal:  J Biomed Inform       Date:  2016-12-16       Impact factor: 6.317

5.  Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases.

Authors:  Sebastian Schneeweiss; Wesley Eddings; Robert J Glynn; Elisabetta Patorno; Jeremy Rassen; Jessica M Franklin
Journal:  Epidemiology       Date:  2017-03       Impact factor: 4.822

6.  Comparing the performance of propensity score methods in healthcare database studies with rare outcomes.

Authors:  Jessica M Franklin; Wesley Eddings; Peter C Austin; Elizabeth A Stuart; Sebastian Schneeweiss
Journal:  Stat Med       Date:  2017-02-16       Impact factor: 2.373

7.  Outcome-adaptive lasso: Variable selection for causal inference.

Authors:  Susan M Shortreed; Ashkan Ertefaie
Journal:  Biometrics       Date:  2017-03-08       Impact factor: 2.571

8.  The role of the c-statistic in variable selection for propensity score models.

Authors:  Daniel Westreich; Stephen R Cole; Michele Jonsson Funk; M Alan Brookhart; Til Stürmer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-12-09       Impact factor: 2.890

9.  Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.

Authors:  Meijia Zhou; Shirley V Wang; Charles E Leonard; Joshua J Gagne; Candace Fuller; Christian Hampp; Patrick Archdeacon; Sengwee Toh; Aarthi Iyer; Tiffany Siu Woodworth; Elizabeth Cavagnaro; Catherine A Panozzo; Sophia Axtman; Ryan M Carnahan; Elizabeth A Chrischilles; Sean Hennessy
Journal:  Epidemiology       Date:  2017-11       Impact factor: 4.822

10.  The performance of different propensity score methods for estimating marginal hazard ratios.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2012-12-12       Impact factor: 2.373

View more
  42 in total

1.  Applied comparison of large-scale propensity score matching and cardinality matching for causal inference in observational research.

Authors:  Stephen P Fortin; Stephen S Johnston; Martijn J Schuemie
Journal:  BMC Med Res Methodol       Date:  2021-05-24       Impact factor: 4.615

2.  How Confident Are We about Observational Findings in Healthcare: A Benchmark Study.

Authors:  Martijn J Schuemie; M Soledad Cepeda; Marc A Suchard; Jianxiao Yang; Yuxi Tian; Alejandro Schuler; Patrick B Ryan; David Madigan; George Hripcsak
Journal:  Harv Data Sci Rev       Date:  2020-01-31

3.  The emerging landscape of health research based on biobanks linked to electronic health records: Existing resources, statistical challenges, and potential opportunities.

Authors:  Lauren J Beesley; Maxwell Salvatore; Lars G Fritsche; Anita Pandit; Arvind Rao; Chad Brummett; Cristen J Willer; Lynda D Lisabeth; Bhramar Mukherjee
Journal:  Stat Med       Date:  2019-12-20       Impact factor: 2.373

4.  Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19.

Authors:  Ravindra Ganesh; Colin F Pawlowski; John C O'Horo; Lori L Arndt; Richard F Arndt; Sarah J Bell; Dennis M Bierle; Molly Destro Borgen; Sara N Hanson; Alexander Heyliger; Jennifer J Larsen; Patrick J Lenehan; Robert Orenstein; Arjun Puranik; Leigh L Speicher; Sidna M Tulledge-Scheitel; A J Venkatakrishnan; Caroline G Wilker; Andrew D Badley; Raymund R Razonable
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 14.808

5.  Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Authors:  Seng Chan You; Yeunsook Rho; Behnood Bikdeli; Jiwoo Kim; Anastasios Siapos; James Weaver; Ajit Londhe; Jaehyeong Cho; Jimyung Park; Martijn Schuemie; Marc A Suchard; David Madigan; George Hripcsak; Aakriti Gupta; Christian G Reich; Patrick B Ryan; Rae Woong Park; Harlan M Krumholz
Journal:  JAMA       Date:  2020-10-27       Impact factor: 56.272

6.  Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.

Authors:  Marc A Suchard; Martijn J Schuemie; Harlan M Krumholz; Seng Chan You; RuiJun Chen; Nicole Pratt; Christian G Reich; Jon Duke; David Madigan; George Hripcsak; Patrick B Ryan
Journal:  Lancet       Date:  2019-10-24       Impact factor: 79.321

7.  Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study.

Authors:  Seng Chan You; Harlan M Krumholz; Marc A Suchard; Martijn J Schuemie; George Hripcsak; RuiJun Chen; Steven Shea; Jon Duke; Nicole Pratt; Christian G Reich; David Madigan; Patrick B Ryan; Rae Woong Park; Sungha Park
Journal:  Hypertension       Date:  2021-03-29       Impact factor: 10.190

8.  Deep propensity network using a sparse autoencoder for estimation of treatment effects.

Authors:  Shantanu Ghosh; Jiang Bian; Yi Guo; Mattia Prosperi
Journal:  J Am Med Inform Assoc       Date:  2021-06-12       Impact factor: 4.497

9.  Bagged random causal networks for interventional queries on observational biomedical datasets.

Authors:  Mattia Prosperi; Yi Guo; Jiang Bian
Journal:  J Biomed Inform       Date:  2021-02-04       Impact factor: 6.317

10.  The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database.

Authors:  Gyu Lee Kim; Yu Hyeon Yi; Hye Rim Hwang; Jinmi Kim; Youngmin Park; Yun Jin Kim; Jeong Gyu Lee; Young Jin Tak; Seung Hun Lee; Sang Yeoup Lee; Youn Hye Cho; Eun Ju Park; Youngin Lee
Journal:  J Clin Med       Date:  2021-05-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.